CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

December 1, 2026

Study Completion Date

January 15, 2027

Conditions

B Lymphocytic LeukemiaB Lymphoblastic Lymphoma

Interventions

DEVICE

CAR T cell injection

intravenous injection

Trial Locations (2)

RECRUITING

Department of Pediatrics, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin

NOT_YET_RECRUITING

InstituteHBDH, Tianjin

All Listed Sponsors

lead

Zhu Xiaofan

OTHER